(Q44614799)

4 December 2017

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial (English)

1 reference

4 December 2017

1 reference

Delmas PD

1

1 reference

4 December 2017

Genant HK

2

1 reference

4 December 2017

Crans GG

3

1 reference

4 December 2017

Stock JL

4

1 reference

4 December 2017

Wong M

5

1 reference

4 December 2017

Siris E

6

1 reference

4 December 2017

Adachi JD

7

1 reference

4 December 2017

1 October 2003

1 reference

4 December 2017

1 reference

4 December 2017

33

1 reference

4 December 2017

522-532

1 reference

4 December 2017

4

1 reference

Osteoporosis prevention, diagnosis, and therapy

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Relationship of bone turnover to bone density and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Mechanical consequences of bone loss in cancellous bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Risk of hip fracture in women with vertebral fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Vertebral fractures predict subsequent fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Risk of new vertebral fracture in the year following a fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Comparative calibration without a gold standard

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Updated data on proximal femur bone mineral levels of US adults

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Vertebral fractures in osteoporosis: a new method for clinical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Clinical consequences of vertebral fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900241-2

7 January 2021

10.1016/S8756-3282(03)00241-2

Identifiers

DOI

1 reference

release_i6m63nyn7zhotib5bj32umn7zu

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i6m63nyn7zhotib5bj32umn7zu

24 November 2022

mapped directly with Wikidata item

1 reference